Thrivent Financial for Lutherans
IMMU

Thrivent Financial for Lutherans’s Immunomedics Inc IMMU Stock Holding History

Thrivent Financial for Lutherans’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-93,632
Closed -$3.32M – 2433
2020
Q2 		$3.32M Sell
93,632
-46,563
-33% -$1.36M 0.01% 839
2020
Q1 		$1.89M Buy
140,195
+368
+0.3% +$6.19K 0.01% 977
2019
Q4 		$2.96M Buy
139,827
+14,749
+12% +$260K 0.01% 869
2019
Q3 		$1.66M Buy
125,078
+3,707
+3% +$54.5K 0.01% 1103
2019
Q2 		$1.68M Buy
121,371
+1,568
+1% +$23.6K 0.01% 1098
2019
Q1 		$2.3M Buy
119,803
+2,662
+2% +$42.9K 0.01% 890
2018
Q4 		$1.67M Buy
117,141
+12,098
+12% +$240K 0.01% 902
2018
Q3 		$2.19M Buy
+105,043
New +$2.49M 0.01% 864
2017
Q4 		– Sell
-4,951
Closed -$69K – 2349
2017
Q3 		$69K Buy
+4,951
New +$49.3K ﹤0.01% 1958

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Thrivent Financial for Lutherans's IMMU Position: Q3 2020 in Review

Thrivent Financial for Lutherans sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 93,632 shares — an estimated $3.32M sold.

Thrivent Financial for Lutherans first reported a position in IMMU in Q3 2017 and held it in 9 quarters. The position peaked at $3.32M in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Thrivent Financial for Lutherans reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 93,632 Immunomedics Inc shares in Q3 2020, an estimated $3.32M.
  • Thrivent Financial for Lutherans first reported a position in Immunomedics Inc in Q3 2017 and held it in 9 quarters.
  • Thrivent Financial for Lutherans's Immunomedics Inc position peaked at $3.32M in Q2 2020.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2020, filed 10 Nov 2020.